Editorial
doi: 10.1080/13543784.2023.2193679.
Epub 2023 Mar 23.
Venetoclax in acute myeloid leukemia
Affiliations
- PMID: 36933006
- DOI: 10.1080/13543784.2023.2193679
Item in Clipboard
Editorial
Venetoclax in acute myeloid leukemia
Expert Opin Investig Drugs.
2023 Apr.
No abstract available
Keywords: AML; Venetoclax; therapy.
Similar articles
-
Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold?Blood Cancer J. 2020 Jan 28;10(1):10. doi: 10.1038/s41408-020-0281-x. Blood Cancer J. 2020. PMID: 31992691 Free PMC article. No abstract available.
-
The preclinical efficacy of the novel hypomethylating agent NTX-301 as a monotherapy and in combination with venetoclax in acute myeloid leukemia.Blood Cancer J. 2022 Apr 11;12(4):57. doi: 10.1038/s41408-022-00664-y. Blood Cancer J. 2022. PMID: 35410412 Free PMC article. No abstract available.
-
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).Blood Cancer J. 2024 Feb 20;14(1):32. doi: 10.1038/s41408-024-01000-2. Blood Cancer J. 2024. PMID: 38378617 Free PMC article.
-
Mechanisms for resistance in AML insights into molecular pathways mediating resistance to venetoclax.Best Pract Res Clin Haematol. 2021 Mar;34(1):101251. doi: 10.1016/j.beha.2021.101251. Epub 2021 Feb 6. Best Pract Res Clin Haematol. 2021. PMID: 33762105 Review.
-
Hypomethylating agents with venetoclax: have we discovered the holy grail?Curr Opin Hematol. 2020 Mar;27(2):76-80. doi: 10.1097/MOH.0000000000000560. Curr Opin Hematol. 2020. PMID: 31895103 Review.
Cited by
-
A combination of Dihydroartemisinin and Venetoclax enhances antitumor effect in AML via C-MYC/BCL-XL/MCL-1 triple targeting.Discov Oncol. 2025 Apr 9;16(1):496. doi: 10.1007/s12672-025-02242-7. Discov Oncol. 2025. PMID: 40202582 Free PMC article.
-
Evaluation and Prognostic Impact of Nutrition in Patients with Acute Leukemia: A Narrative Review.Curr Oncol Rep. 2025 May;27(5):625-633. doi: 10.1007/s11912-025-01671-5. Epub 2025 Apr 8. Curr Oncol Rep. 2025. PMID: 40195210 Review.
-
Pharmacological Inhibition of PIP4K2 Potentiates Venetoclax-Induced Apoptosis in Acute Myeloid Leukemia.Int J Mol Sci. 2023 Nov 29;24(23):16899. doi: 10.3390/ijms242316899. Int J Mol Sci. 2023. PMID: 38069220 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
